| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0091 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.002 | 1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |